Find Academic Supervisors

Scott L. Diamond is the Arthur E. Humphrey Professor of Chemical and Biomolecular Engineering and Bioengineering at the University of Pennsylvania's School of Engineering and Applied Sciences. He serves as Director of the Penn Center for Molecular Discovery, Director of the Penn Biotechnology Masters Program (one of the largest in the country with over 130 students), and Associate Director of the Institute for Medicine and Engineering (IME). His laboratory is located in the Roy and Diana Vagelos Laboratories at 3340 Smith Walk, 1020 Vagelos Research Laboratories, Philadelphia, PA. Diamond's research spans multiple interconnected fields in blood biology and biotechnology. His work focuses on mechanobiology, thrombolysis, coagulation, bioadhesion, gene therapy, drug/device development, proteomics, drug discovery, systems biology, and microfluidics. His laboratory has developed numerous specialized microfluidic devices for studying blood clotting under various flow conditions, including 8-channel devices for high-throughput clotting assays, side-view devices for clot structure analysis, stenosis devices for high shear clotting assays, and impingement-post devices for studying von Willebrand factor fibers. Diamond's research group has pioneered approaches to model and predict blood function using systems biology principles. His team has developed computational models that integrate reaction-transport phenomena with platelet signaling networks to predict thrombus formation under flow. These models have enabled the development of 'virtual blood' computer simulations that can predict the effectiveness of anticoagulation drugs for individual patients, contributing significantly to personalized medicine approaches in hemostasis and thrombosis. His extensive publication record demonstrates a consistent focus on understanding the fundamental mechanisms of blood clot formation and dissolution. Recent work has emphasized microfluidic approaches for point-of-care diagnostics, patient-specific modeling of platelet function, and the development of novel therapeutic strategies for thrombotic disorders. His research bridges engineering principles with clinical hematology to address significant challenges in cardiovascular medicine. NSF National Young Investigator Award NIH FIRST Award American Heart Association Established Investigator Award AIChE Allan P. Colburn Award George Heilmeier Excellence in Research Award Elected Fellow of the Biomedical Engineering Society (BMES) Diamond has secured significant research funding, including a $2.8 million NIH grant for 'Blood Systems Biology' and a $9.5 million NIH grant for the Penn Center for Molecular Discovery. His laboratory has developed numerous microfluidic devices for blood analysis and has collaborated extensively with clinicians and industry partners. Diamond has served on advisory committees for NSF, NIH, AHA, and NASA, and has consulted extensively for industry and government. With over 180 publications and patents, his work has significantly advanced the understanding of blood clotting mechanisms and the development of diagnostic and therapeutic approaches for thrombotic disorders.

• Mechanobiology
• Thrombolysis
• Coagulation
• +10 more

Patrick M. Gillevet is a Professor and Director of the Microbiome Analysis Center at George Mason University, with a primary appointment in the Biology Department and affiliate faculty status in the School of Systems Biology. His career focuses on integrating genomics, bioinformatics, and molecular ecology to study microbiome interactions in human health and environmental systems, including the development of multitag sequencing for high-throughput microbial analysis. Education: Ph.D., Biochemistry, University of Manitoba (1982) B.S., Microbiology, University of Toronto (1976) His research explores dysbiosis in the human microbiome (gut, mouth, urogenital, respiratory tracts) and its role in diseases, cognitive function, and social behavior. He pioneered the concept of the "metabiome" to describe host-microbiome interactions in systems biology. Key projects include analyzing multitag sequencing for evolutionary studies and microbial community characterization in ecosystems. Recent publications highlight collaborations on gut microbiome trends in cirrhosis, alcohol use disorder, and antibiotic resistance, with a focus on cross-sectional and longitudinal analyses. His work spans clinical trials (e.g., griffithsin gel), dietary interventions, and environmental microbiome studies.

• Molecular Ecology
• Bioinformatics
• Genomics
• +5 more

Xiaoyu Che is an Assistant Professor of Biostatistics at Columbia University's Mailman School of Public Health, where he serves as the principal biostatistician in the Center for Infection and Immunity (CII) at Columbia University Irving Medical Center. His work bridges statistical methodology with biomedical research, focusing on complex disease mechanisms through advanced data analysis approaches. Dr. Che received his academic training at prestigious institutions: BS in Mathematics from Zhejiang University (2006) PhD in Mathematics from Claremont Graduate University (2013) Dr. Che's research program centers on the development and application of statistical methods for multi-omics analyses, with particular focus on understanding the pathogenesis of chronic and neurodevelopmental conditions. His work spans multiple domains including Autism Spectrum Disorder (ASD), Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and Gulf War Illness (GWI). He employs sophisticated biostatistical approaches to integrate diverse biological data types, revealing novel insights into disease mechanisms. His methodological expertise includes Bayesian statistics, metabolomic analysis, immune signature identification, and microbiome characterization, all aimed at translating complex biological data into meaningful clinical insights. Analysis of Dr. Che's publication record reveals a strong thematic focus on applying advanced statistical methods to understand complex disease mechanisms. His work consistently bridges biostatistical innovation with biomedical discovery, particularly in the areas of neurodevelopmental disorders and chronic fatigue conditions. The publications demonstrate progression from foundational methodological work to increasingly sophisticated multi-omics integration approaches, reflecting both technical growth and expanding research impact. His collaborative approach is evident through numerous high-impact publications with interdisciplinary teams across Columbia University and beyond. Dr. Che teaches BIST P8104: Probability in the Biostatistics MS degree program at Columbia, demonstrating his commitment to training the next generation of biostatisticians. While specific grant information isn't detailed in the provided materials, his extensive publication record across multiple high-impact journals suggests successful grant funding supporting his research program. As principal biostatistician in the Center for Infection and Immunity, Dr. Che plays a critical role in the analytical framework of the center's research initiatives. His work supports the center's mission to understand the relationship between infectious agents and human health through rigorous quantitative analysis. The collaborative nature of his research is evident in the diverse range of co-authors spanning immunology, virology, microbiology, and clinical medicine.

• Autism Spectrum Disorder
• Biostatistical Methods
• Chronic disease
• +4 more

Mohamed S. Alsammak, MD, is an Associate Professor in the Department of Clinical Pathology & Laboratory Medicine at the Lewis Katz School of Medicine, Temple University. He also serves as Director of the Blood Bank/Transfusion Medicine at Temple University Hospital, where he practices in the fields of Hematologic Pathology, Blood Banking, and Transfusion Medicine. His clinical and research interests include: Transfusion medicine Therapeutic apheresis Thrombotic thrombocytopenic purpura Sickle cell disease and red cell exchange Patient blood management Hematopathology Coagulation disorders The trend in his publications reflects a strong focus on clinical applications of apheresis, transfusion support in complex medical and surgical settings, coagulation abnormalities, and laboratory-based clinical research. His work often addresses rare hematologic conditions and perioperative challenges, with increasing attention to physician well-being and transplant-related desensitization protocols. Scientific awards and distinctions include: MD with Medal of Distinction, Arabian Gulf University Competitive Scholarships for Medical School, Sponsored by The Ministry of Education in Bahrain Dr. Alsammak has been actively involved in multidisciplinary clinical research, frequently collaborating with teams in hematology, critical care, transplantation, and obstetrics. His publications suggest engagement in national surveys and case-based reporting, contributing to best practices in apheresis and transfusion medicine. While formal grant information is not available, his leadership role and scholarly output indicate active participation in clinical innovation and education. He is affiliated with key professional organizations such as the American Society for Apheresis, AABB, and the College of American Pathologists, underscoring his commitment to advancing standards in blood banking and transfusion safety.

• Transfusion Medicine
• Hematopathology
• Coagulation
• +7 more

Dr. Ai-ris Yonekura Collier serves as Assistant Professor in Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School and Staff Physician in the Department of Obstetrics and Gynecology at Beth Israel Deaconess Medical Center (BIDMC). She concurrently holds a Physician-Scientist position at BIDMC's Center for Virology and Vaccine Research (CVVR) and co-directs the Clinical Trials Unit within CVVR, establishing a critical bridge between maternal-fetal medicine and virology research. Her academic foundation includes: B.S. in Biology (Minor: Chemistry) from Massachusetts Institute of Technology (2005) M.D. from Harvard Medical School through Harvard-MIT Health Sciences & Technology Program (2011) Obstetrics & Gynecology Residency at UCLA (2011-2015) Maternal-Fetal Medicine Fellowship at BIDMC (2015-2018) Dr. Collier's research centers on maternal immune tolerance mechanisms in placental development, with dual investigative tracks: (1) Characterizing cellular immune phenotypes in pregnancy disorders like preeclampsia and fetal growth restriction, and (2) Analyzing infectious disease impacts including Zika virus and SARS-CoV-2. Her translational approach integrates longitudinal biospecimen repositories with clinical observations, emphasizing the inclusion of pregnant populations in vaccine trials. As an educator, she actively mentors trainees and advocates for policy changes in clinical trial design. Recent publications demonstrate a pronounced focus on viral immunology during the pandemic era, with 7 of 9 recent papers addressing SARS-CoV-2 variants, vaccine responses, and Mpox immunity. These works reveal consistent methodological themes: neutralization assays against emerging variants, analysis of coagulation-inflammation pathways in vaccine complications, and sensitive diagnostic approaches for prior infections. Concurrently, she maintains her foundational research in placental immunology, exemplified by cytokine studies in preeclampsia. Her scientific recognition includes: NIH Loan Repayment Program (2018-2020) Mentor Award from ACOG District I (2021) Translational Research Hubs Spark Grant Award (2022) Rookie of the Year Award at BIDMC (2016) Multiple research presentation awards from perinatal societies As Principal Investigator of the Yonekura Collier Laboratory and Co-Director of the Clinical Trials Unit, she manages substantial grant funding including NIH/NICHD support and institutional translational grants. Her leadership extends to hospital-wide initiatives like the BIDMC COVID-19 Biorepository, while her advocacy focuses on rectifying historical exclusions of pregnant individuals from clinical research. She maintains active collaborations across Harvard's immunology and virology departments. The Yonekura Collier Laboratory operates within CVVR's collaborative ecosystem, integrating with Dan Barouch's research group and the broader Harvard Medical School community. Her team combines clinical obstetric expertise with advanced immunological techniques to investigate fetal-maternal interface biology, creating a unique interdisciplinary hub for perinatal infectious disease research.

• Maternal-Fetal Medicine
• Immunology in Pregnancy
• Infectious Diseases in Pregnancy
• +3 more

Dr. Andreia Marina Ionescu serves as Associate Professor of Biology and Principal Investigator at Northeastern University since July 2020, leading research in skeletal development and regenerative medicine. Education: PhD, University of Rochester (NY) Postdoctoral Fellowship, Harvard Medical School Research Interests: Her lab pioneers investigations into growth plate stem cell hierarchies, FoxA2+ long-term skeletal stem cells (LTSSCs), and osteoarthritis mechanisms. Key focuses include: Transcriptional regulation of chondrocyte differentiation Cartilage regeneration via stem cell populations Nanoparticle-based gene delivery for OA treatment PTHrP signaling in skeletal growth Publication Trends: Recent work (2022-2024) demonstrates integration of single-cell transcriptomics with functional studies to map skeletal stem cell lineages, revealing FoxA2+ LTSSCs as critical regeneration mediators. Parallel efforts develop charge-reversed exosomes for targeted cartilage therapy, bridging developmental biology and translational orthopedics. Scientific Awards: NSF CAREER Award (2024) Advising and Grants: Mentors four graduate students, twelve undergraduate researchers, and two senior scientists. Lab operations are supported by NSF CAREER funding and institutional resources for skeletal biology research. Lab and Team: The Ionescu lab integrates wet-lab biologists (Dr. Muruganandan Shanmugam, Dr. Yu Zhou) with computational expertise (bioinformatician Dr. Yu Zhou) to address skeletal regeneration challenges through molecular, cellular, and tissue-level approaches.

• Developmental Biology
• Skeletal Stem Cell Research
• Osteoarthritis
• +3 more

Sriram Neelamegham is the UB Distinguished Professor of Chemical & Biological Engineering, Biomedical Engineering, and Medicine at the University at Buffalo, SUNY. His research focuses on applying engineering principles to study molecular mechanisms of blood cell interactions in diseases such as inflammation, thrombosis, and cancer. He leads the Bioengineering Laboratory within the School of Engineering and Applied Sciences. Education: PhD in Chemical/Biomedical Engineering, Rice University, 1996 B.Tech in Chemical Engineering, Indian Institute of Technology Delhi, 1991 Research Interests: Systems Glycobiology: Investigating glycan biosynthesis and its role in disease Leukocyte and Platelet Adhesion Dynamics under Fluid Flow Von Willebrand Factor (VWF) Structure-Function Relationships Engineering Glycoengineered Therapeutics and Diagnostic Tools Key Contributions: Developed computational models and experimental tools for glycosylation pathway analysis Discovered mechanisms of VWF conformational changes under shear stress Pioneered glycoengineering strategies for stem cell targeting Awards & Recognition: NIH Independent Scientist Award (2015) SUNY Chancellor's Award for Excellence (2015) AIMBE Fellow (2012) and BMES Fellow (2019) 2018 Schoellkopf Medal (ACS) Lab Activities: Recruitment of postdocs, full-time, and part-time research technicians Development of glycan-engineered technologies for drug delivery and diagnostics Collaborations with biomedical industries and academic institutions

• Bioengineering
• Systems Glycobiology
• Thrombosis & Hemostasis
• +3 more

Paul Kingsley, Ph.D. is a Research Assistant Professor (Part-Time) in the Department of Pediatrics, Hematology and Oncology at the University of Rochester School of Medicine and Dentistry. His academic credentials include a Ph.D. and M.S. in Developmental Biology from the University of Rochester (1992, 1987) and a B.A. in Biology from Reed College (1982), followed by a Cancer Center Fellowship in Hematopoiesis at the University of Rochester School of Medicine and Dentistry (1992-1994). Dr. Kingsley's research focuses on: Embryonic Hematopoiesis Erythroid Differentiation Ontogeny of Hematopoietic Progenitors Erythroid Precursor Self Renewal His laboratory employs diverse approaches including subtractive hybridization, degenerate PCR, genechip technology (Affymetrix), and in situ hybridization to investigate blood formation in mammalian embryos. His work examines how hematopoiesis initiates in the yolk sac, migrates to the fetal liver, and finally homes to the bone marrow at the end of gestation. Dr. Kingsley's publication record demonstrates consistent focus on molecular mechanisms of blood cell development, with recent work emphasizing erythroid maturation, hematopoietic stem cell regulation, and chromatin dynamics during erythropoiesis. His research spans from fundamental developmental biology to potential clinical applications in blood disorders and radiation protection. Key research contributions include: Mechanisms of erythroblast enucleation and maturation Regulation of hematopoietic stem cell specification and migration Chromatin remodeling during late-stage erythropoiesis Mitochondrial iron metabolism in heme synthesis Developmental origins of immune cell lineages Effects of radiation on hematopoietic recovery Dr. Kingsley has maintained a productive research career with extensive collaboration, particularly with Dr. James Palis, resulting in numerous high-impact publications in journals such as Nature, Science, Blood, and The EMBO Journal.

• Embryonic Hematopoiesis
• Erythroid Differentiation
• Ontogeny of Hematopoietic Progenitors
• +3 more

Mingyang Tan is a Postdoctoral Research Associate at the Department of Mechanical and Industrial Engineering, Northeastern University. Their research focuses on intersections of biomedical engineering, rheology, 3D printing, and materials science, with applications in pharmaceutical manufacturing and biofluid dynamics. Role: Postdoctoral Research Associate Department: Mechanical and Industrial Engineering Email: mi.tan@northeastern.edu Research Interests Mingyang Tan's work explores rheological properties of complex systems, including 3D bioprinting for tissue engineering, magnetic particle dynamics in fluids, and microrheology of biofluids. Their studies address biomedical applications like plasma coagulation and osteochondral graft development, alongside innovations in pharmaceutical manufacturing using binder jetting 3D printing . Publication Trends Recent articles highlight advances in additive manufacturing , biomaterials , and microrheology , particularly for medical and pharmaceutical contexts. Key themes include magnetic alignment of particles, sustained drug delivery , and anisotropic suspensions . The work spans computational simulations, experimental validations, and translational applications. Scientific Awards Advising & Grants No formal advising or grant information is explicitly mentioned in the provided text. Labs & Collaborations Details about specific labs, teams, or collaborative networks are unavailable in the provided materials.

• Biomedical Engineering
• Mechanical Engineering
• Rheology
• +7 more

Paula T. Hammond is the David H. Koch Professor of Engineering, head of the Department of Chemical Engineering, and a member of the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology. A pioneer in nanotechnology and polymer science, she develops layer-by-layer (LbL) nanoparticle platforms for cancer therapy, wound healing, vaccine delivery, and synthetic blood substitutes. Her work bridges chemical engineering, materials science, and biomedical applications with a focus on translational research. BS in Chemical Engineering, MIT (1984) MS in Chemical Engineering, Georgia Tech (1988) PhD in Chemical Engineering, MIT (1993) Research Interests : Hammond’s research spans nano-based drug delivery , immunotherapy , biomedical implants , and self-assembling materials . Her lab designs LbL nanoparticles for ovarian cancer , glioblastoma , and intractable cancers , enabling combination therapies (siRNA, proteins, chemotherapy). Recent work includes ML-driven nanoparticle design and two-component hemostatic systems for internal bleeding. Article Trends : Her recent publications (2025) emphasize modular LbL nanoparticles for hematopoietic stem cells , cancer immunostimulation , and multi-drug delivery . Broader keywords include Nanotechnology , Biomaterials , RNA Therapeutics , while sub-fields cover targeted drug release , immune activation , and synthetic oxygen transport . Scientific Awards : National Medal of Technology and Innovation (2024) Othmer Gold Medal (2024) Benjamin Franklin Medal in Chemistry (2024) James R. Killian Faculty Achievement Award (2023-24) MIT Institute Professor (2021) Three-time National Academy member (Sciences, Engineering, Medicine) Advising & Leadership : Hammond has mentored over 60 graduate students and postdocs , co-founded LayerBio, Inc. , and serves on scientific advisory boards for Moderna and Burroughs-Wellcome Fund . She chairs MIT’s Initiative on Faculty Race and Diversity and contributes to national science policy through PCAST. Lab & Collaborations : The Hammond Lab at MIT’s Koch Institute develops LbL nanoparticle systems with applications in cancer, regenerative medicine, and hemostasis. Collaborations include the MIT Institute for Soldier Nanotechnology and partnerships with clinicians, biologists, and engineers.

• Nanotechnology
• Chemical Engineering
• Drug Delivery
• +12 more

Dr. Kristen L. Fardelmann is an Assistant Professor of Anesthesiology at Yale School of Medicine and Yale New Haven Hospital. She holds a medical degree (MD) from the University of Connecticut (2013) and a BS in Molecular and Cell Biology from the same institution. Dr. Fardelmann completed her Anesthesiology residency at New York Presbyterian-Weill Cornell Medical Center (2017) and a fellowship in Obstetric Anesthesiology at the University of North Carolina Chapel Hill (2018). Her research focuses on obstetric anesthesia, perioperative pain management, maternal-fetal medicine, and critical care in pregnancy. Key areas include optimizing cesarean delivery analgesia, managing opioid use disorders during pregnancy, and applying rotational thromboelastometry (ROTEM) to assess coagulopathy in obstetric populations. She has also contributed to studies on SARS-CoV-2 placental infection and rare vascular anomalies in pregnancy. Dr. Fardelmann’s publications emphasize clinical practice improvements, such as refining anesthesia protocols for cesarean sections and non-obstetric surgeries in pregnant patients. She collaborates with experts in cardiology, infectious disease, and maternal-fetal medicine to address complex peripartum challenges. Her work bridges clinical care and translational research, aiming to enhance patient safety and outcomes in high-risk obstetric scenarios. Professional certifications include Board Certification in Anesthesiology (American Board of Anesthesiology, 2018). Her research has been published in journals like Anesthesiology , Obstetric Anesthesia Digest , and Journal of Clinical Monitoring and Computing .

• Obstetric Anesthesiology
• Pain Management
• Perioperative Medicine
• +3 more

MICHEL SANNER is a Professor of Molecular Biology at the Department of Integrative Structural and Computational Biology at Scripps Research. He holds a PhD in Computer Science from the University of Haute Alsace, France (1992). His research focuses on computational methods for molecular interactions, molecular graphics, and component-based software development. Notable contributions include the AutoDock suite (for molecular docking), PMV (a molecular visualization environment), and Vision (a visual programming tool). His research group develops tools like AutoDock CrankPep for peptide docking and F2Dock for protein-protein interactions. These tools are widely used in drug discovery and structural biology. His work emphasizes software engineering principles to create adaptable computational pipelines for analyzing macromolecular structures and simulating interactions. Publications span topics like peptide-docking methodologies, ligand-binding site prediction, and GPU-accelerated docking algorithms. His articles highlight advancements in computational methods for understanding protein-ligand interactions, with applications in anticoagulant research and HIV/FIV protease inhibition. Collaborations include work with Arthur J. Olson and David S. Goodsell on docking methodologies.

• Molecular Interactions
• Molecular Graphics
• Component-Based Software
• +3 more

Courtney Perry, DO is an Assistant Professor in the Department of Internal Medicine at the University of Kentucky College of Medicine, with a focus on Digestive Health and Nutrition. She is actively involved in clinical care, research, and academic teaching within the Division of Gastroenterology. Medical School: DO, Rocky Vista College of Osteopathic Medicine Residency: Internal Medicine, University of Kentucky, Lexington, KY Fellowship: Gastroenterology, University of Kentucky, Lexington, KY Dr. Perry's research interests are centered in gastroenterology, particularly inflammatory bowel disease (IBD), intestinal cell biology, and public health aspects of digestive diseases. Her work spans clinical research, epidemiology, and translational studies, with a strong emphasis on patient outcomes and health education. She has also contributed to interdisciplinary research in digital health and pediatric nutrition. Her recent publications reflect a diverse yet focused research trajectory. Themes include IBD epidemiology and treatment challenges, molecular mechanisms in intestinal health, digital transformation in pathology, and public health strategies for obesity and nutrition. Her work appears in high-impact journals such as Cellular and Molecular Gastroenterology and Hepatology , Blood Advances , and The Lancet Digital Health , indicating both clinical and translational relevance. Prevalence and characterization of anti-VWF antibodies in type 3 VWD (2024) Digital-physical divide in pathology research (2023) Urban Legend: IBD epidemiology knowledge gaps (2023) Opioid use in IBD – ethical considerations (2021) SIRT2 in intestinal cell regulation (2020) Dr. Perry has collaborated with multidisciplinary teams across institutions and has contributed to review articles and editorials on public health and clinical ethics. While no formal advising or grant information is listed, her active publication record suggests ongoing research engagement and mentorship. She is affiliated with the University of Kentucky's Gill Heart and Vascular Institute and contributes to the academic mission of the Internal Medicine residency and fellowship programs.

• Gastroenterology
• Inflammatory Bowel Disease (IBD)
• Digestive Health
• +6 more

Juan R. Cebral is a Professor in the Departments of Bioengineering and Mechanical Engineering at the Volgenau School of Engineering, George Mason University. He leads the Computational Hemodynamics Laboratory and maintains affiliations with the Center for Computational Fluid Dynamics and the Krasnow Institute for Advanced Studies. His research bridges engineering and medicine to address life-threatening vascular conditions through computational modeling. He earned his PhD in Computational Sciences and Informatics from George Mason University in 1996 and completed his MSc in Physics at the University of Buenos Aires, Argentina in 1991. Originally from Plaza Huincul in Patagonia, Argentina, he has built an internationally recognized research program focused on patient-specific modeling of cerebral blood flow. Professor Cebral's research centers on using computational fluid dynamics to model hemodynamics in cerebral aneurysms and other vascular diseases. His work investigates the relationship between blood flow patterns and aneurysm development, rupture, and treatment outcomes, with particular focus on flow diversion techniques. His lab develops methods for constructing patient-specific anatomical models from medical images and applies them to enhance risk assessment and personalize endovascular treatments. His research has been funded by the National Institutes of Health, American Heart Association, Whitaker Foundation, and industry partners including Philips Healthcare and Boston Scientific. His recent publications (2024-2025) demonstrate continued focus on cerebral aneurysm hemodynamics with increasing attention to flow diversion mechanisms, fibrin accumulation, and aneurysm wall integrity. His work integrates computational modeling with biological and clinical data to better understand aneurysm growth patterns, rupture risks, and treatment outcomes, featuring sophisticated multi-scale modeling approaches that connect hemodynamic conditions with biological responses in the vessel wall. His research has been funded by prestigious organizations including the National Institutes of Health, American Heart Association, and Whitaker Foundation His work has been featured in Forbes Argentina (August 5, 2024 and October 7, 2024) His student Medhini Sosale earned the prestigious Goldwater Scholarship (April 12, 2022) Professor Cebral mentors students in bioengineering research, with several advisees receiving significant recognition. His research program is supported by multiple NIH grants including R01 NS076491 (Computational and Biological Approach to Flow Diversion) and R21 NS094780 (Improved evaluation of PCOM aneurysms), as well as funding from Philips Medical Systems and Mayo Clinic. He collaborates extensively with clinicians at Inova Fairfax Hospital, Mayo Clinic, and international institutions to translate computational findings into clinical practice. He directs the Computational Hemodynamics Laboratory at George Mason University, which specializes in patient-specific modeling of blood flows in cerebral aneurysms. The lab works closely with the Center for Computational Fluid Dynamics and collaborates with clinicians and researchers from Inova Fairfax Hospital, Mayo Clinic, Allegheny General Hospital, Kuopio Medical Center in Finland, Clinica ENERI in Argentina, University of Pittsburgh, and Barcelona Supercomputing Center.

• Computational Fluid Dynamics
• Hemodynamics
• Cerebral Aneurysms
• +7 more

Wolfgang Bergmeier, PhD, is a Professor in the Department of Biochemistry and Biophysics at the University of North Carolina at Chapel Hill. He is a member of the UNC Lineberger Comprehensive Cancer Center and the UNC Blood Research Center, where he leads research on the signaling mechanisms regulating megakaryocyte and platelet function in health and disease. His laboratory employs a multidisciplinary approach including biochemistry, cell and molecular biology, immunology, cutting-edge microscopy, and animal models to investigate platelet biology and its implications for human disease. Dr. Bergmeier's research focuses on understanding small GTPase signaling in platelets, particularly Rap1, and its role in hemostasis, thrombosis, and cancer. His work has made significant contributions to our understanding of how platelets secure vascular integrity, how they contribute to cancer progression and treatment complications, and how platelet function can be optimized for therapeutic purposes. His laboratory has developed novel mouse models and intravital imaging platforms to study platelet function in real-time. Analysis of Dr. Bergmeier's recent publications reveals a strong focus on platelet signaling mechanisms, particularly Rap1 and other small GTPases, and their implications for hemostasis, thrombosis, and cancer. His research spans from fundamental molecular mechanisms to translational applications, including development of novel antithrombotic strategies, optimization of platelet transfusion therapy, and understanding the complex relationship between platelets and cancer progression. Dr. Bergmeier has received numerous awards including the Outstanding Investigator Award from the National Heart, Lung and Blood Institute (NIH) in 2019, the American Heart Association ATVB Special Recognition Award in Thrombosis in 2016, and the Established Investigator Award from the American Heart Association in 2014. He has served as Chair of the 9th Symposium of Hemostasis in Chapel Hill (2018) and Vice Chair of the Gordon Research Conference on the Cell Biology of Platelets and Megakaryocytes (2017). He is also an Associate Editor for the Journal of Thrombosis and Hemostasis. His laboratory actively collaborates with clinical researchers at UNC, particularly with Dr. Nigel Mackman on cancer-related platelet research and with Drs. Flick and Wolberg on the interplay of platelets and the coagulation system. The Bergmeier Lab is part of the UNC BCBP Green Lab initiative, demonstrating a commitment to sustainability in research practices.

• Platelet Signaling
• Megakaryocyte Biology
• Small GTPase Signaling
• +4 more